Panacea Biotec appoints Susheel Umesh as chief executive, Rajeeva Kumar Mangalum, as COO & Dinesh Singla as sr VP

Our Bureau, MumbaiWednesday, November 20, 2019, 15:10 Hrs  [IST]

Panacea Biotec Limited, one of India’s leading pharmaceutical and biotechnology company, has appointed Susheel Umesh as the chief executive of domestic formulations.

Susheel Umesh brings in 27 years of experience, deep understanding of pharmaceutical industry and has managed P&Ls at Sanofi and Abbott. He has led multiple roles spanning from managing global brands to running a large commercial operation to create value and establish differentiation in the branded generic space. He has managed large teams and enjoys building and transforming teams to deliver great results through innovative practices.

The company also announced the elevation of Rajeeva Kumar Mangalum as chief operating officer for the pharmaceutical operations and Dinesh Singla as senior vice president- pharma research and pharma regulatory affairs.

Rajeeva Kumar Mangalum brings in 35 years of pharmaceutical manufacturing experience out of which he has spent 25 years in Panacea Biotec Limited. He is a result driven, self –motivated and action oriented person with an ability to successfully translate strategy into action. Has led and managed large teams and believes in achieving business objectives through team work.

Dinesh Singla brings in 24 years of pharmaceutical research experience out of which he has spent 12 years in Panacea Biotec Limited. He is a result driven, focused, self – motivated scientist with business acumen and an ability to successfully translate strategy into business. Has led teams to deliver innovation-based products both for domestic and international markets.

According to a company press release, Ankesh Jain, director - sales & marketing who was directly looking after the domestic formulations business, will focus on growing formulations business internationally, with special focus on emerging markets, besides development and launch of new products in existing export markets.

Ankesh Jain will work closely with Susheel Umesh over the next few months to ensure smooth transition.